Clinical trial
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without…
NCT00117962 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00117962 |
|---|---|
| Title | Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer |
| Official title | A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eli Lilly and Company Industry Bristol-Myers Squibb |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | cetuximab, carboplatin, pemetrexed disodium, radiation therapy |
| Enrollment | 109 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Sep 1, 2012 |
| First posted | Jul 11, 2005 |
| Last update posted | Oct 7, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: